Be nimble, be ready: how to tackle regulatory uncertainty in clinical trials
A constantly evolving landscape for clinical trials and drug development research has created challenges for the sector to not only…
Interviews
From real to regulatory: why RWD needs trial-grade standards
Potentially “groundbreaking” FDA gene therapy pathway leaves key issues unresolved
FDA’s latest CGT guidance streamlines path for in vivo CAR-T development
Animal testing alternatives to dominate, but not overnight
Walgreens sets sights on clinical trial network growth in recruitment drive
FDA genAI reviews hinge on clarity of dossiers
Synthetic control arms: full impact yet to be realised
